Here are the latest quarterly results of IND. SWIFT. For more details, see the IND. SWIFT financial fact sheet and IND. SWIFT share price. For a sector overview, read our pharmaceuticals sector report.
| No. of Mths Qtr. Ending |
3
Jun-23* |
3
Sep-23* |
3
Dec-23* |
3
Mar-24* |
3
Jun-24* |
3
Sep-24* |
3
Dec-24* |
3
Mar-25* |
8-Qtr Chart Click to enlarge |
|
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | Rs m | 1,485 | 1,159 | 1,026 | 1,352 | 1,139 | 1,363 | 1,201 | 1,449 | |
| Other income | Rs m | 56 | 32 | 26 | 460 | 399 | 46 | 26 | 87 | |
| Turnover | Rs m | 1,542 | 1,191 | 1,052 | 1,812 | 1,538 | 1,410 | 1,228 | 1,536 | |
| Expenses | Rs m | 1,301 | 1,048 | 981 | 1,205 | 1,106 | 1,219 | 1,128 | 1,478 | |
| Gross profit | Rs m | 184 | 111 | 45 | 151 | 32 | 144 | 73 | 2,698 | |
| Depreciation | Rs m | 67 | 67 | 68 | 69 | 54 | 54 | 56 | 72 | |
| Interest | Rs m | 149 | 183 | 153 | 144 | 95 | 95 | 99 | 102 | |
| Profit before tax | Rs m | 24 | -107 | -150 | 398 | 282 | 41 | -55 | 2,611 | |
| Tax | Rs m | 0 | 0 | 0 | 22 | 0 | 0 | 0 | 45 | |
| Profit after tax | Rs m | 24 | -107 | -150 | 375 | 282 | 41 | -55 | 2,566 | |
| Gross profit margin | % | 12.4 | 9.6 | 4.4 | 11.1 | 2.8 | 10.6 | 6.1 | 186.2 | |
| Effective tax rate | % | 0.0 | -0.0 | -0.0 | 5.6 | 0.0 | 0.0 | -0.0 | 1.7 | |
| Net profit margin | % | 1.6 | -9.2 | -14.6 | 27.8 | 24.8 | 3.0 | -4.6 | 177.1 | |
| Diluted EPS | Rs | 0.4 | -2.0 | -2.8 | 6.9 | 5.2 | 0.8 | -1.0 | 47.4 | |
| Diluted EPS (TTM) | Rs | 8.1 | 8.1 | 5.5 | 2.6 | 7.4 | 10.1 | 11.9 | 52.3 | |
Asian equities were largely subdued on Monday as investors remained cautious about oil prices, which posted strong gains last week amid the absence of progress towards ending the Iran conflict, keeping concerns over inflation elevated.